{"protocolSection": {"identificationModule": {"nctId": "NCT00200850", "orgStudyIdInfo": {"id": "H-2005-0193"}, "secondaryIdInfos": [{"id": "R21AT002326-01A1", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/R21AT002326-01A1"}], "organization": {"fullName": "University of Wisconsin, Madison", "class": "OTHER"}, "briefTitle": "Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy", "officialTitle": "Sublingual Immunotherapy in Dust Mite Allergy"}, "statusModule": {"statusVerifiedDate": "2019-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2006-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2008-10", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-10", "type": "ACTUAL"}, "studyFirstSubmitDate": "2005-09-13", "studyFirstSubmitQcDate": "2005-09-13", "studyFirstPostDateStruct": {"date": "2005-09-20", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-04-15", "resultsFirstSubmitQcDate": "2019-05-21", "resultsFirstPostDateStruct": {"date": "2019-06-12", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-05-21", "lastUpdatePostDateStruct": {"date": "2019-06-12", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "University of Wisconsin, Madison", "class": "OTHER"}, "collaborators": [{"name": "National Center for Complementary and Integrative Health (NCCIH)", "class": "NIH"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for patients with intermittent mild asthma caused by dust mites.", "detailedDescription": "Asthma is a serious lung condition that is the leading cause of long-term illness in children. Many common household substances can trigger or worsen an asthma attack. It is important for people to reduce household allergens and learn effective treatments for specific types of asthma. Inhaled short-acting beta agonist such as albuterol is the standard treatment for mild, intermittent asthma. However, recent studies have shown that adding allergen-specific immunotherapy to your current asthma therapy can help to control asthma symptoms. This study will determine the safety and effectiveness of SLIT in two different dosing regimens in treating patients with house dust mite-induced allergic rhinitis/mild intermittent asthma.\n\nParticipants will be randomly assigned to receive low dose SLIT, high dose SLIT, or placebo for at least 12 months. House dsut mite-induced allergy skin tests will be performed at study entry, at selected timepoints throughout the study, and at the end of the study. The tests will determine whether SLIT creates an immune tolerance state as well as whether SLIT acts via local or systemic immunological systems."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Breathing", "Allergy", "Mites, House Dust"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 31, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Low dose SLIT", "type": "ACTIVE_COMPARATOR", "description": "Low dose SLIT", "interventionNames": ["Biological: House Dust Mite SLIT"]}, {"label": "High dose SLIT", "type": "ACTIVE_COMPARATOR", "description": "High dose SLIT", "interventionNames": ["Biological: High dose SLIT"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo", "interventionNames": ["Biological: Placebo SLIT"]}], "interventions": [{"type": "BIOLOGICAL", "name": "House Dust Mite SLIT", "description": "low dose SLIT 143 Allergen Units(AU)/ml daily", "armGroupLabels": ["Low dose SLIT"]}, {"type": "BIOLOGICAL", "name": "High dose SLIT", "description": "House Dust Mite SLIT- 10,000 Allergen units(AU)/ml daily", "armGroupLabels": ["High dose SLIT"]}, {"type": "BIOLOGICAL", "name": "Placebo SLIT", "description": "Placebo SLIT daily", "armGroupLabels": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Bronchial Threshold to Allergen Challenge From Baseline to 12-18 Months of Treatment", "description": "Antigen challenge was performed using the antigen house dust mite. Increasing doses of antigen were inhaled and then lung function (using the procedure Spirometry, measuring Forced Expiatory Volume in the 1st second FEV1) was measured after each dose. The challenge was stopped once the lung function (FEV1) was dropped by 20% of percent predicted. The dose of antigen that caused a 20% drop in lung function is considered the bronchial threshold. The higher the dose of antigen that causes the drop in lung function, the higher tolerance a participant has of inhaling house dust mite. This dose was measure at baseline and then again after 12-18 months of treatment with sublingual house dust mite antigen.Cumulative breath units is the unit of measure to indicate how much antigen is tolerated before the FEV1 is dropped by 20%. Cumulative breath units is also known as breath units.", "timeFrame": "baseline and after 12-18 months treatment"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* House dust mite-induced allergic rhinitis/mild intermittent asthma\n\nExclusion Criteria:\n\n* Use of previous allergy immunotherapy for house dust mite asthma\n* Pregnancy or breastfeeding", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "50 Years", "stdAges": ["ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Robert K. Bush, MD", "affiliation": "University of Wisconsin Medical School", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "University of Wisconsin Medical School", "city": "Madison", "state": "Wisconsin", "zip": "53706", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}]}, "referencesModule": {"references": [{"pmid": "21333346", "type": "RESULT", "citation": "Bush RK, Swenson C, Fahlberg B, Evans MD, Esch R, Morris M, Busse WW. House dust mite sublingual immunotherapy: results of a US trial. J Allergy Clin Immunol. 2011 Apr;127(4):974-81.e1-7. doi: 10.1016/j.jaci.2010.11.045. Epub 2011 Feb 18. Erratum In: J Allergy Clin Immunol. 2011 Jun;127(6):1561. Morris, Mary [added]."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Out of 31 participants enrolled, 6 participants withdrew due to non-treatment-ascribed-event, 4 participants withdrew due to treatment-ascribed-events.\n\nOnly 21 participants completed the study.", "groups": [{"id": "FG000", "title": "Low Dose", "description": "Low dose SLIT\n\nHose Dust Mite SLIT: low dose SLIT 143 AU/ml daily"}, {"id": "FG001", "title": "High Dose", "description": "High dose SLIT\n\nHigh dose SLIT: House Dust Mite SLIT- 10,000 AU/ml daily"}, {"id": "FG002", "title": "Placebo", "description": "Placebo\n\nPlacebo SLIT: Placebo SLIT daily"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "10"}, {"groupId": "FG001", "numSubjects": "10"}, {"groupId": "FG002", "numSubjects": "11"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "9"}, {"groupId": "FG002", "numSubjects": "5"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "6"}]}], "dropWithdraws": [{"type": "relocation", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "too busy", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}]}, {"type": "Pregnancy", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Poor adherence", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "optic neuritis", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Low Dose", "description": "Low dose SLIT\n\nHose Dust Mite SLIT: low dose SLIT 143 AU/ml daily"}, {"id": "BG001", "title": "High Dose", "description": "High dose SLIT\n\nHigh dose SLIT: House Dust Mite SLIT- 10,000 AU/ml daily"}, {"id": "BG002", "title": "Placebo", "description": "Placebo\n\nPlacebo SLIT: Placebo SLIT daily"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "31"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "28.9", "spread": "5.088"}, {"groupId": "BG001", "value": "33.8", "spread": "7.359"}, {"groupId": "BG002", "value": "29.3", "spread": "8.634"}, {"groupId": "BG003", "value": "30.6", "spread": "7.559"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "8"}, {"groupId": "BG003", "value": "22"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "9"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "31"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "11"}, {"groupId": "BG003", "value": "29"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Bronchial Threshold to Allergen Challenge From Baseline to 12-18 Months of Treatment", "description": "Antigen challenge was performed using the antigen house dust mite. Increasing doses of antigen were inhaled and then lung function (using the procedure Spirometry, measuring Forced Expiatory Volume in the 1st second FEV1) was measured after each dose. The challenge was stopped once the lung function (FEV1) was dropped by 20% of percent predicted. The dose of antigen that caused a 20% drop in lung function is considered the bronchial threshold. The higher the dose of antigen that causes the drop in lung function, the higher tolerance a participant has of inhaling house dust mite. This dose was measure at baseline and then again after 12-18 months of treatment with sublingual house dust mite antigen.Cumulative breath units is the unit of measure to indicate how much antigen is tolerated before the FEV1 is dropped by 20%. Cumulative breath units is also known as breath units.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "cumulative breath units", "timeFrame": "baseline and after 12-18 months treatment", "groups": [{"id": "OG000", "title": "Low Dose", "description": "Low dose SLIT\n\nHose Dust Mite SLIT: low dose SLIT 143 AU/ml daily"}, {"id": "OG001", "title": "High Dose", "description": "High dose SLIT\n\nHigh dose SLIT: House Dust Mite SLIT- 10,000 AU/ml daily"}, {"id": "OG002", "title": "Placebo", "description": "Placebo\n\nPlacebo SLIT: Placebo SLIT daily"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "9"}, {"groupId": "OG002", "value": "5"}]}], "classes": [{"title": "Baseline dose of antigen", "categories": [{"measurements": [{"groupId": "OG000", "value": "75.0", "spread": "56.7"}, {"groupId": "OG001", "value": "69.5", "spread": "46.8"}, {"groupId": "OG002", "value": "141.4", "spread": "147"}]}]}, {"title": "Post treatment dose of antigen", "categories": [{"measurements": [{"groupId": "OG000", "value": "74.8", "spread": "57.3"}, {"groupId": "OG001", "value": "100.9", "spread": "35.2"}, {"groupId": "OG002", "value": "83.3", "spread": "59.3"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Up to 18 months", "eventGroups": [{"id": "EG000", "title": "Low Dose", "description": "Low dose SLIT\n\nHose Dust Mite SLIT: low dose SLIT 143 AU/ml daily", "deathsNumAffected": 0, "deathsNumAtRisk": 10, "seriousNumAffected": 0, "seriousNumAtRisk": 10, "otherNumAffected": 10, "otherNumAtRisk": 10}, {"id": "EG001", "title": "High Dose", "description": "High dose SLIT\n\nHigh dose SLIT: House Dust Mite SLIT- 10,000 AU/ml daily", "deathsNumAffected": 0, "deathsNumAtRisk": 10, "seriousNumAffected": 0, "seriousNumAtRisk": 10, "otherNumAffected": 10, "otherNumAtRisk": 10}, {"id": "EG002", "title": "Placebo", "description": "Placebo\n\nPlacebo SLIT: Placebo SLIT daily", "deathsNumAffected": 0, "deathsNumAtRisk": 11, "seriousNumAffected": 0, "seriousNumAtRisk": 11, "otherNumAffected": 11, "otherNumAtRisk": 11}], "otherEvents": [{"term": "oral lesion", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Oral lesion or canker sore", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 3, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 5, "numAffected": 4, "numAtRisk": 11}]}, {"term": "throat irritation", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Sore throat or strep throat", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Upper respiratory infection", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "URI and/or asthma symptoms, pueumonia", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 17, "numAffected": 7, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 9, "numAffected": 6, "numAtRisk": 11}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 11}]}, {"term": "Gastrointestinal issues", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Constipation, black stool, nausea", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 5, "numAffected": 3, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Flu", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Sinus infection", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 2, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 3, "numAffected": 2, "numAtRisk": 11}]}, {"term": "Head cold", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 11}]}, {"term": "Headache", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Sprain", "organSystem": "Musculoskeletal and connective tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "hand wrist, ankle or back sprain", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 6, "numAffected": 3, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 4, "numAffected": 4, "numAtRisk": 11}]}, {"term": "Reproductive issues", "organSystem": "Reproductive system and breast disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Clogged milk duct, irregular menses, mood swings with menstruation,", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 11}]}, {"term": "Eye infection", "organSystem": "Eye disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Eye infection or pink eye", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 7, "numAffected": 4, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 11}]}, {"term": "Dermatologic issues", "organSystem": "Skin and subcutaneous tissue disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Mole removed with stitches, skin breakout, cyst on head", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 4, "numAffected": 3, "numAtRisk": 11}]}, {"term": "Ear infection", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 11}]}, {"term": "Fatigue", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Optic neuritis", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Pain due to wisdom teeth extraction", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}, {"term": "Muffled hearing", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 11}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Gina Crisafi", "organization": "UW Madison", "email": "gmc@medicine.wisc.edu", "phone": "608-262-5240"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000092542", "term": "Dust Mite Allergy"}, {"id": "D000006967", "term": "Hypersensitivity"}], "ancestors": [{"id": "D000007154", "term": "Immune System Diseases"}, {"id": "D000012221", "term": "Rhinitis, Allergic, Perennial"}, {"id": "D000065631", "term": "Rhinitis, Allergic"}, {"id": "D000012220", "term": "Rhinitis"}, {"id": "D000009668", "term": "Nose Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000010038", "term": "Otorhinolaryngologic Diseases"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "asFound": "Allergy", "relevance": "HIGH"}, {"id": "M2939", "name": "Dust Mite Allergy", "asFound": "Dust Mite Allergy", "relevance": "HIGH"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "M15049", "name": "Rhinitis", "relevance": "LOW"}, {"id": "M30545", "name": "Rhinitis, Allergic", "relevance": "LOW"}, {"id": "M15050", "name": "Rhinitis, Allergic, Perennial", "relevance": "LOW"}, {"id": "M12604", "name": "Nose Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M12961", "name": "Otorhinolaryngologic Diseases", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "BC09", "name": "Ear, Nose, and Throat Diseases"}, {"abbrev": "BC01", "name": "Infections"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M2853", "name": "Immunomodulating Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}